Entrada Therapeutics
Entrada Therapeutics is a biologics delivered to cytosol founded in 2016.
2
Funding Rounds
$175.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca**** Nu********** | - | - | - |
| Di*** Do*** | - | - | |
| Ma** Th***** | - | - | |
| Pe*** S. Ki* | - | - | - |
| Ku** Pa**** | - | - | - |
| To** Fo*** | - | - | - |
| Jo** F. Cr***** | - | - | - |
Funding series
Funding Series Analysis
The company Entrada Therapeutics has raised a total of $116m in funding over 2 rounds.
Key Insights:
- Entrada Therapeutics, Inc. funding round, April 2021: $116m
- Entrada Therapeutics funding round, December 2018: $59m
Entrada Therapeutics, Inc. funding round, April 2021
$116m
Entrada Therapeutics funding round, December 2018
$59m
Industries
Entrada Therapeutics is active in the following industries:
- Rare disease
- Biomedical engineering
- Biopharmaceutical
- Engineering
- Therapeutics
- Technology
- Biology
- Biotechnology
- Synthetic chemistry